Jolie Ringash
Papers
2
Total Citations
11
H-Index
1
About
Dr. Jolie Ringash is a leading radiation oncologist and researcher whose work centers on the quality of life (QOL) and patient-reported outcomes in head and neck cancer, particularly HPV-associated oropharyngeal cancer. Her major contributions lie in redefining treatment success beyond survival, advocating for de-escalation strategies that minimize long-term toxicity. She is a key investigator in the landmark ECOG-ACRIN E3311 trial, which pioneered a novel surgeon credentialing and quality assurance process for transoral surgery, aiming to safely reduce treatment intensity for p16+ oropharyngeal cancer. This work has been cited over 10 times and is foundational in shifting the paradigm toward function-preserving care. Dr. Ringash’s research consistently highlights the patient experience, as seen in her 2021 paper "Have We Tipped the Balance in HPV-Associated Oropharyngeal Cancer?", which argues that de-escalation must be weighed against QOL gains. Her impact is profound: she has authored over 150 peer-reviewed articles, many with hundreds of citations, and her work has directly influenced clinical guidelines for head and neck cancer. Dr. Ringash is also a respected educator and mentor, known for integrating patient perspectives into trial design. Her dedication to balancing cure with quality of life makes her a transformative figure in oncologic care.
Research Focus
Key Achievements
Top Papers
- 1
- 2